Earnings Per Share

3 Months Ended

Mar. 31, 2021

The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020 (in thousands, except per share amounts):


	Three Months Ended March 31,
	2021		2020
Earnings per Common Share - basic:
Numerator:
Net income	$	29,311	$	175,309
Net income attributable to noncontrolling interests in CPLP from continuing operations	(6)		(302)
Net income attributable to other noncontrolling interests	(195)		(64)
Net income available to common stockholders	$	29,110	$	174,943

Denominator:
Weighted average common shares - basic	148,624		147,424


Net income per common share - basic	$	0.20	$	1.19

Earnings per common share - diluted:
Numerator:
Net income	$	29,311	$	175,309
Net income attributable to other noncontrolling interests	(195)		(64)
Net income available for common stockholders before allocation of net income attributable to noncontrolling interests in CPLP	$	29,116	$	175,245

Denominator:
Weighted average common shares - basic	148,624		147,424
Add:
Potential dilutive common shares - stock options	4		15
Potential dilutive common shares - restricted stock units, less shares assumed purchased at market price	72		2
Weighted average units of CPLP convertible into common shares	25		1,120
Weighted average common shares - diluted	148,725		148,561


Net income per common share - diluted	$	0.20	$	1.18

Anti-dilutive stock options represent stock options whose exercise price exceeds the average market value of the Company’s stock. As of March 31, 2021 and December 31, 2020, there were no anti-dilutive stock options included in the calculation of dilutive weighted average shares. As of March 31, 2021, the Company has no stock options outstanding.